Holder | Position | Change | Date | |
---|---|---|---|---|
Marshall Wace LLP | 0.9% | 0 | 10-Dec-2024 | View History |
Kintbury Capital LLP | 0.51% | 0 | 20-Nov-2024 | View History |
WorldQuant LLC | 0.5% | 0 | 20-Nov-2024 | View History |
Greenvale Capital LLP | 0.74% | 0 | 23-Oct-2024 | View History |
AKO Capital LLP | 1.22% | 0 | 15-Oct-2024 | View History |
Citadel Advisors LLC | 0.51% | 0 | 02-Aug-2024 | View History |
Holder | Position | Change (%) | Date | |
---|---|---|---|---|
Marshall Wace LLP | 0.5% | 27-Oct-2020 | View History | |
Marshall Wace LLP | 0.49% | 01-Oct-2020 | View History | |
Marshall Wace LLP | 0.51% | 22-Sep-2020 | View History | |
Marshall Wace LLP | 0.48% | 15-Jul-2020 | View History | |
Marshall Wace LLP | 0.51% | 08-Jul-2020 | View History | |
Marshall Wace LLP | 0.49% | 06-Jul-2020 | View History | |
Marshall Wace LLP | 0.51% | 01-Jul-2020 | View History | |
Marshall Wace LLP | 0.48% | 08-Apr-2020 | View History | |
Marshall Wace LLP | 0.52% | 06-Apr-2020 | View History | |
Marshall Wace LLP | 0.69% | 02-Apr-2020 | View History | |
Marshall Wace LLP | 0.76% | 30-Mar-2020 | View History | |
Marshall Wace LLP | 0.88% | 26-Mar-2020 | View History | |
Marshall Wace LLP | 0.99% | 17-Mar-2020 | View History | |
Marshall Wace LLP | 1.01% | 16-Mar-2020 | View History | |
Marshall Wace LLP | 0.95% | 13-Mar-2020 | View History | |
Marshall Wace LLP | 0.88% | 11-Mar-2020 | View History | |
Marshall Wace LLP | 0.79% | 10-Mar-2020 | View History | |
Marshall Wace LLP | 0.6% | 06-Mar-2020 | View History |
Smith & Nephew is a British medical technology company that develops, manufactures, and sells medical devices. Products include arthroscopy, trauma, clinical therapy, and orthopaedic reconstruction products. Smith & Nephew's products are sold in over 100 countries, including Europe, the Americas, Asia Pacific, the Middle East, and Africa.
Smith & Nephew operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management.
Smith & Nephew's shares are traded in London and New York, and the company is a constituent of the UK's FTSE100.
Smith and Nephew share price launched at 182p in 1988.